{"title":"儿童慢性肥厚性腮腺炎HIV感染的临床和免疫学特征。","authors":"L Madelena, I Drăgan, M Mihordea","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The study refers to children of 0-15 years of age, infected with HIV and who developed a chronic hypertrophic parotitis (CHP), admitted to the \"Colentina\" Clinic of Infectious Diseases--Paediatrics in Bucharest, between January 1, 1990 and May 15, 1993. Among the total number of 579 HIV infection cases hospitalized in the above-mentioned period, 135 were associated with CHP, hence an incidence of 23.3%. The HIV infection was defined by two ELISA-positive assays, confirmed by a Western-blot test. No specific laboratory test for the diagnosis of CHP in the course of HIV infection was available. The detection of a uni- or bilateral painless parotid enlargement, without signs of skin inflammation in HIV-infected children, was conclusive for the diagnosis of CHP. IgG type anticytomegalovirus antibodies were detected in 41.17% (7/17) and anti-Toxoplasma antibodies in 50% of the tested cases (4/8). The immunogram performed in 85 children showed increased IgG values in 92.94% of cases (79/85) and increased IgM values in 85.88% (73/85). There was recorded a significant increase in the levels of immunoglobulins, especially of IgM, which exceeded 13 times the normal values. The CD8 cells were frequently normal or increased (94.44%, respectively 34/36). CHP appeared before a marked deterioration of CD4 cells, simultaneously with the CD8 cells proliferation. CHP developed at a stage of the HIV infection when the medium-term prognosis was still considered favourable.</p>","PeriodicalId":79532,"journal":{"name":"Romanian journal of virology","volume":"46 3-4","pages":"135-43"},"PeriodicalIF":0.0000,"publicationDate":"1995-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and immunological features of the HIV infection associated with chronic hypertrophic parotitis in children.\",\"authors\":\"L Madelena, I Drăgan, M Mihordea\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The study refers to children of 0-15 years of age, infected with HIV and who developed a chronic hypertrophic parotitis (CHP), admitted to the \\\"Colentina\\\" Clinic of Infectious Diseases--Paediatrics in Bucharest, between January 1, 1990 and May 15, 1993. Among the total number of 579 HIV infection cases hospitalized in the above-mentioned period, 135 were associated with CHP, hence an incidence of 23.3%. The HIV infection was defined by two ELISA-positive assays, confirmed by a Western-blot test. No specific laboratory test for the diagnosis of CHP in the course of HIV infection was available. The detection of a uni- or bilateral painless parotid enlargement, without signs of skin inflammation in HIV-infected children, was conclusive for the diagnosis of CHP. IgG type anticytomegalovirus antibodies were detected in 41.17% (7/17) and anti-Toxoplasma antibodies in 50% of the tested cases (4/8). The immunogram performed in 85 children showed increased IgG values in 92.94% of cases (79/85) and increased IgM values in 85.88% (73/85). There was recorded a significant increase in the levels of immunoglobulins, especially of IgM, which exceeded 13 times the normal values. The CD8 cells were frequently normal or increased (94.44%, respectively 34/36). CHP appeared before a marked deterioration of CD4 cells, simultaneously with the CD8 cells proliferation. CHP developed at a stage of the HIV infection when the medium-term prognosis was still considered favourable.</p>\",\"PeriodicalId\":79532,\"journal\":{\"name\":\"Romanian journal of virology\",\"volume\":\"46 3-4\",\"pages\":\"135-43\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Romanian journal of virology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian journal of virology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical and immunological features of the HIV infection associated with chronic hypertrophic parotitis in children.
The study refers to children of 0-15 years of age, infected with HIV and who developed a chronic hypertrophic parotitis (CHP), admitted to the "Colentina" Clinic of Infectious Diseases--Paediatrics in Bucharest, between January 1, 1990 and May 15, 1993. Among the total number of 579 HIV infection cases hospitalized in the above-mentioned period, 135 were associated with CHP, hence an incidence of 23.3%. The HIV infection was defined by two ELISA-positive assays, confirmed by a Western-blot test. No specific laboratory test for the diagnosis of CHP in the course of HIV infection was available. The detection of a uni- or bilateral painless parotid enlargement, without signs of skin inflammation in HIV-infected children, was conclusive for the diagnosis of CHP. IgG type anticytomegalovirus antibodies were detected in 41.17% (7/17) and anti-Toxoplasma antibodies in 50% of the tested cases (4/8). The immunogram performed in 85 children showed increased IgG values in 92.94% of cases (79/85) and increased IgM values in 85.88% (73/85). There was recorded a significant increase in the levels of immunoglobulins, especially of IgM, which exceeded 13 times the normal values. The CD8 cells were frequently normal or increased (94.44%, respectively 34/36). CHP appeared before a marked deterioration of CD4 cells, simultaneously with the CD8 cells proliferation. CHP developed at a stage of the HIV infection when the medium-term prognosis was still considered favourable.